Kaplan MA - Search Results

1

Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer.

Ilhan Y, Tatli AM, Teker F, Onder AH, Kose F, Geredeli C, Karaagac M, Kaplan MA, Inanc M, Goktas Aydin S, Kargi A, Arak H, Ozturk B, Besen AA, Selvi O, Korkmaz M, Oruc Z, Bozkurt O, Bilici A, Bayram S, Dae SA, Ozdogan M, Coskun HS, Sezgin Goksu S. Ilhan Y, et al. Among authors: kaplan ma. Int J Gynecol Cancer. 2022 Apr 4;32(4):502-507. doi: 10.1136/ijgc-2021-003165. Int J Gynecol Cancer. 2022. PMID: 35086927

2

Gemcitabine and cisplatin combination chemotherapy in triple negative metastatic breast cancer previously treated with a taxane/anthracycline chemotherapy; multicenter experience.

Ozkan M, Berk V, Kaplan MA, Benekli M, Coskun U, Bilici A, Gumus M, Alkis N, Dane F, Ozdemir NY, Colak D, Dikilitas M. Ozkan M, et al. Among authors: kaplan ma. Neoplasma. 2012;59(1):38-42. doi: 10.4149/neo_2012_005. Neoplasma. 2012. PMID: 22103897

3

Docetaxel and Cisplatin Plus Fluorouracil compared with Modified Docetaxel, Cisplatin, and 5-Fluorouracil as first-line therapy for advanced gastric cancer: a retrospective analysis of single institution.

Inal A, Kaplan MA, Kucukoner M, Isikdogan A. Inal A, et al. Among authors: kaplan ma. Neoplasma. 2012;59(2):233-6. doi: 10.4149/neo_2012_030. Neoplasma. 2012. PMID: 22248282 Clinical Trial.

4

Gemcitabine alone versus combination of gemcitabine and cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a retrospective analysis of multicenter study.

Inal A, Kos FT, Algin E, Yildiz R, Dikiltas M, Unek IT, Colak D, Elkiran ET, Helvaci K, Geredeli C, Dane F, Balakan O, Kaplan MA, Durnali AG, Harputoglu H, Goksel G, Ozdemir N, Buyukberber S, Gumus M, Kucukoner M, Ozkan M, Uncu D, Benekli M, Isikdogan A. Inal A, et al. Among authors: kaplan ma. Neoplasma. 2012;59(3):297-301. doi: 10.4149/neo_2012_038. Neoplasma. 2012. PMID: 22329849

5

Prognostic factors for second-line treatment of advanced non-small-cell lung cancer: retrospective analysis at a single institution.

Inal A, Kaplan MA, Kucukoner M, Urakci Z, Karakus A, Isikdogan A. Inal A, et al. Among authors: kaplan ma. Asian Pac J Cancer Prev. 2012;13(4):1281-4. doi: 10.7314/apjcp.2012.13.4.1281. Asian Pac J Cancer Prev. 2012. PMID: 22799319 Free article.

6

Biological subtypes and survival outcomes in breast cancer patients with brain metastases (study of the Anatolian Society of Medical Oncology).

Kaplan MA, Isikdogan A, Koca D, Kucukoner M, Gumusay O, Yildiz R, Dayan A, Demir L, Geredeli C, Kocer M, Arslan UY, Inal A, Unal OU, Mert AG, Bilici M, Ozkan M, Elkiran ET, Yaman S, Durnalı AG, Suner A, Alici S, Tarhan MO, Boruban C, Urakci Z, Buyukberber S. Kaplan MA, et al. Oncology. 2012;83(3):141-50. doi: 10.1159/000338782. Epub 2012 Jul 18. Oncology. 2012. PMID: 22814315

7

Cisplatin-based therapy for the treatment of elderly patients with non-small-cell lung cancer: a retrospective analysis of a single institution.

Inal A, Kaplan MA, Kucukoner M, Urakci Z, Karakus A, Isikdogan A. Inal A, et al. Among authors: kaplan ma. Asian Pac J Cancer Prev. 2012;13(5):1837-40. doi: 10.7314/apjcp.2012.13.5.1837. Asian Pac J Cancer Prev. 2012. PMID: 22901132 Free article. Clinical Trial.

8

Prognostic factors in elderly patients with advanced non-small cell lung cancer treated with first-line cisplatin-based chemotherapy: a retrospective analysis of single institution.

Inal A, Kaplan MA, Kucukoner M, Karakus A, Isikdogan A. Inal A, et al. Among authors: kaplan ma. J BUON. 2012 Jul-Sep;17(3):533-6. J BUON. 2012. PMID: 23033295

9

Prognostic analysis of patients with operable gastric cancer and tolerability to adjuvant radio-chemo-therapy.

Kucukoner M, Arpaci E, Isikdogan A, Bilici M, Uncu D, Cetin B, Dane F, Inanc M, Ekinci AS, Inal A, Cayir K, Yetisyigit T, Ozdemir N, Kaplan MA, Aksoy S, Alkıs N, Tekin SB, Eroglu C, Turhal S, Buyukberber S. Kucukoner M, et al. Among authors: kaplan ma. Neoplasma. 2013;60(1):19-25. doi: 10.4149/neo_2013_003. Neoplasma. 2013. PMID: 23067212

10

Prognostic factors in first-line chemotherapy treated metastatic gastric cancer patients: a retrospective study.

Inal A, Kaplan MA, Kuçukoner M, Urakci Z, Guven M, Nas N, Yunce M, Işikdogan A. Inal A, et al. Among authors: kaplan ma. Asian Pac J Cancer Prev. 2012;13(8):3869-72. doi: 10.7314/apjcp.2012.13.8.3869. Asian Pac J Cancer Prev. 2012. PMID: 23098485 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

448 results

Search Page